Please wait a minute...
IMAGE/TABLE DETAILS
Recurrence of nasopharyngeal carcinoma and application of endoscopic surgery
Yan JIANG
Journal of Otolaryngology and Ophthalmology of Shandong University    2019, 33 (2): 1-11.   DOI: 10.6040/j.issn.1673-3770.1.2019.011
Abstract   (2586 HTML45 PDF(pc) (23617KB)(626)  

Radiotherapy is the conventional treatment for nasopharyngeal carcinoma. Although the 5-year survival rate has greatly improved, there are still several cases of recurrent or residual nasopharyngeal carcinoma. The treatment principles of recurrent or residual lesions include second-course radiotherapy, chemotherapy, and surgery. The complications following radical radiotherapy and second-course radiotherapy seriously affect the quality of life in patients. The current surgical methods include open surgery and endoscopic surgery. Open surgery can provide a sufficiently open field of operation, but is associated with some serious damage. Endoscopic nasopharyngeal carcinoma resection has been carried out lately, and only few medical institutions in China perform these operations. However, with the emergence of the concept of endoscopic skull base surgery and new medical instruments and equipment, endoscopic nasopharyngeal carcinoma surgery has become a good surgical choice. However, this requires strict surgical indications, skills of endoscopic skull-base surgery, and long-term follow-up.


Fig.7 A 48-year-old man with local recurrence of nasopharyngeal carcinoma, 2 years after radiotherapy, refused two-way radiotherapy and underwent total endoscopic resection of the nasopharyngeal carcinoma and postoperative chemotherapy, with a 24-month follow-up
A. Left nasopharyngeal parietal tumor; B. Endoscopic resection of the tumor (a. inner margin, b. outer margin, c. upper margin, d. lower margin, e. deep margin); C. Appearance of the nasopharynx, 24 months after surgery.
Extracts from the Article
首程放疗后,部分患者出现严重的鼻咽干燥、张口困难、吞咽障碍,或者严重的听力下降、药物无法缓解的头痛等症状,患者接受再程放疗的意愿往往大打折扣,即便是首程放疗后2~3年后出现复发,患者也常抗拒再程放疗。对于该类患者,在综合考虑其复发病灶范围、患者机体耐受程度、抗再程放疗耐受力后,可以将内镜下手术切除复发病灶作为一种选择,但术前术后一般需联合化疗药物治疗(图7)。
Other Images/Table from this Article